– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 – – Company announced first wholly owned ...

Just so you know, HuffPost UK may collect a share of sales or other compensation from the links on this page if you decide to ...

Atlanta rapper Ca$h Out’s shocking life plus 70-year sentence left many confused at first. But as details of a long-running ...

A 2026 informational overview of Boltz Retro Device features, game library specifications, setup considerations, and what ...

NEW YORK — Longtime media executive Jeff Shell is leaving Paramount, in a move that arrives amid a messy legal battle and the ...

Real-time index price for DOW Composite [Test] (COMP), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Ben Affleck's reported decision to transfer his stake in a $60 million mansion to Jennifer Lopez has sparked speculation ...

Other ways to pay your financial adviser ...

The Company believes that the combination of continued success at the Tuning Fork Uranium Zone and a strong pipeline of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for Timbercreek Financial Corp (TF-T) from The Globe and Mail including charting and trades.